Many users notice faster recovery after workouts, decreased soreness, and stronger performance over time
Syntegons portfolio of compact pharmaceutical cleaning systems for the low, medium and high output ranges prevents potentially harmful substances from compromising operator and patient safety
Glucagon-like peptide-1 analogues in monogenic syndromic obesity: real-world data from a large cohort of Alstrm syndrome patients
If GLP-1 use jumps, there will likely be fewer people with prediabetes and obesity-related type 2 diabetes
Emily Hunt, Thorntons interim infrastructure director, says the concern lies not so much with the summer ahead but with the summers to follow, assuming precipitation stays meager
The FDA confirmed that the tirzepatide shortage was resolved, and compounding pharmacies and outsourcing facilities lost the authority to make it in 2025